Identification of Gene-Set Signature in Early-Stage Hepatocellular Carcinoma and Relevant Immune Characteristics

BACKGROUND: The incidence of hepatocellular carcinoma (HCC) is rising worldwide, and there is limited therapeutic efficacy due to tumor microenvironment heterogeneity and difficulty in early-stage screening. This study aimed to develop and validate a gene set-based signature for early-stage HCC (eHC...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Qijie, Wongpoomchai, Rawiwan, Chariyakornkul, Arpamas, Xiao, Zhangang, Pilapong, Chalermchai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570321/
https://www.ncbi.nlm.nih.gov/pubmed/34745960
http://dx.doi.org/10.3389/fonc.2021.740484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570321/
https://www.ncbi.nlm.nih.gov/pubmed/34745960
http://dx.doi.org/10.3389/fonc.2021.740484

Ejemplares similares